<DOC>
	<DOCNO>NCT01947894</DOCNO>
	<brief_summary>The purpose study assess long term treatment outcomes Growth Hormone treatment patient prescribe treated Genotropin . Also , plan determine relationship clinical status , dosage schedule response Genotropin treatment . This study also contribute knowledge adult Growth Hormone Deficiency , include transition period Childhood Onset Growth Hormone Deficiency treatment .</brief_summary>
	<brief_title>A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency ( GHD ) Patients</brief_title>
	<detailed_description>Patients within inclusion criterion ask participate study .</detailed_description>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Adult patient 18 year age fulfil one three alternative ac ; 1 . Newly diagnose GHD accord current medical standard . 2 . Diagnosed GHD 2013 previously treat Genotropin follow KIMS® . 3 . Transition patient diagnose COGHD 2013 . Prescribed Genotropin time inclusion . Evidence personally sign date informed consent document indicate patient ( legally acceptable representative ) inform pertinent aspect study . Patients participate concurrent clinical interventional trial nonauthorized authorize study medication use , participation Swedish KIMS® Xtended . Concurrent study include study interventional item ( whether medication device ) allow .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>